Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Phase I/II Clinical Trial to Evaluate the Safety, Immunogenicity, and Impact on Virological Control of the Investigational RNA-based Vaccine BNT168 in Adults Living With or Without HIV

NCT07698600 is registered in ClinicalTrials.gov with BioNTech SE as lead sponsor.

NCT NCT07698600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Phase I/II Clinical Trial to Evaluate the Safety, Immunogenicity, and Impact on Virological Control of the Investigational RNA-based Vaccine BNT168 in Adults Living With or Without HIV
Lead sponsor
BioNTech SE
Phase
Phase 1
Overall status
Recruiting
Start date
August 4, 2026
Completion date
February 29, 2028
Enrollment
126 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv -1 infection